Revamping the Rules: FDA, HHS Strengthen Stance on Pharmaceutical Ads
The current administration is strengthening its stance on the direct-to-consumer advertising practices of pharmaceutical companies. Notably, the Food and Drug Administration and the U.S. Department of Health and Human Services are collaborating in efforts to curtail the ‘adequate provision’ loophole…
